Stachydrine hydrochloride alleviates pressure overload-induced heart failure and calcium mishandling on mice

J Ethnopharmacol. 2020 Feb 10:248:112306. doi: 10.1016/j.jep.2019.112306. Epub 2019 Oct 15.

Abstract

Ethnopharmacological relevance: Traditional Chinese medicine Leonurus japonicus Houtt. has a long history in the treatment of cardiovascular diseases. Stachydrine hydrochloride, the main bioactive ingredient extracted from Leonurus japonicus Houtt., has been shown to have cardioprotective effects. However, the underlying mechanisms of stachydrine hydrochloride haven't been comprehensively studied so far.

Aim of the study: The aim of this study was to investigate the protective role of stachydrine hydrochloride in heart failure and elucidate its possible mechanisms of action.

Materials and methods: In vivo, transverse aorta constriction was carried out in C57BL/6J mice, and thereafter, 7.2 mg/kg telmisartan (a selective AT1R antagonist as positive control) and 12 mg/kg stachydrine hydrochloride was administered daily intragastrically for 4 weeks. Cardiac function was evaluated by assessing morphological changes as well as echocardiographic and haemodynamic parameters. In vitro, neonatal rat cardiomyocytes or adult mice cardiomyocytes were treated with stachydrine hydrochloride and challenged with phenylephrine (α-AR agonist). Ventricular myocytes were isolated from the hearts of C57BL/6J mice by Langendorff crossflow perfusion system. Intracellular calcium was measured by an ion imaging system. The length and movement of sarcomere were traced to evaluate the systolic and diastolic function of single myocardial cells.

Results: Stachydrine hydrochloride improved the cardiac function and calcium transient amplitudes, and inhibited the SR leakage and the amount of sparks in cardiac myocytes isolated from TAC mice. We also demonstrated that stachydrine hydrochloride could ameliorated phenylephrine-induced enhance in sarcomere contraction, calcium transients and calcium sparks. Moreover, our data shown that stachydrine hydrochloride blocked the hyper-phosphorylation of CaMKII, RyR2, PLN, and prevented the disassociation of FKBP12.6 from RyR2.

Conclusion: Our results suggest that stachydrine hydrochloride exerts beneficial therapeutic effects against heart failure. These cardioprotective effects may be associated with the regulation of calcium handling by stachydrine hydrochloride through inhibiting the hyper-phosphorylation of CaMKII.

Keywords: CaMKII pathway; Calcium leak; Calcium mishandling; Heart failure; Stachydrine hydrochloride.

Publication types

  • Comparative Study

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Animals
  • Aorta / physiopathology*
  • Aorta / surgery
  • Arterial Pressure*
  • Calcium Signaling / drug effects*
  • Calcium-Binding Proteins / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Cardiovascular Agents / pharmacology*
  • Cells, Cultured
  • Disease Models, Animal
  • Heart Failure / etiology
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Heart Failure / prevention & control*
  • Male
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / drug effects*
  • Myocytes, Cardiac / metabolism
  • Phosphorylation
  • Proline / analogs & derivatives*
  • Proline / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Sarcomeres / drug effects
  • Sarcomeres / metabolism
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / metabolism
  • Telmisartan / pharmacology
  • Ventricular Function, Left / drug effects*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Calcium-Binding Proteins
  • Cardiovascular Agents
  • Ryanodine Receptor Calcium Release Channel
  • phospholamban
  • ryanodine receptor 2. mouse
  • Proline
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • stachydrine
  • Telmisartan